Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown.
New data presented at 29th ECTRIMS congress reinforce the clinical profile of investigational laquinimod on disease progression and inflammation in relapsing-remitting multiple sclerosis
The fatigue-motor performance paradox in multiple sclerosis.
Neuroradiological evaluation of demyelinating disease.
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
MRI of the cervical nerve roots in the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy: a single-institution, retrospective case-control study.
The role of the sema4D/CD72-dependent signal in the regulation of B-cell activity in multiple sclerosis.
Reply to Article: High inbreeding in the Faroe Islands does not appear to constitute a risk factor for multiple sclerosis.
Accuracy of a custom physical activity and knee angle measurement sensor system for patients with neuromuscular disorders and gait abnormalities.
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction.
Immunopathological patterns from EAE and Theiler's virus infection: Is multiple sclerosis a homogenous 1-stage or heterogenous 2-stage disease?
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Patients' perspectives on quality of mental health care for people with MS.
Differences in oligoclonal bands and visual evoked potentials in patients with radiologically and clinically isolated syndrome.
Central Neuropathic Pain Syndromes.
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.
Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease.
Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Fluoxetine prevents oligodendrocyte cell death by inhibiting microglia activation after spinal cord injury.
Unmet care needs of people with a neurological chronic disease: a cross-sectional study in Italy on Multiple Sclerosis.
Pages
« first
‹ previous
…
331
332
333
334
335
336
337
338
339
…
next ›
last »